Clinical trial

Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy…

NCT00004172 · Northwestern University, Other · Completed

Key facts

NCT number NCT00004172
Title Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
Official title Peripheral Stem Cell Transplantation Protocol for Patients With Previously Treated Advanced Breast Cancer - A Phase II Pilot Study
Lead sponsor Northwestern University, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Breast Cancer
Intervention type Biological, Drug, Procedure, Radiation
Interventions filgrastim, carboplatin, cyclophosphamide, ifosfamide, thiotepa, peripheral blood stem cell transplantation, radiation therapy
Start date Oct 1, 1999
Primary completion Oct 1, 2003
Completion Oct 1, 2003
First posted Sep 16, 2004
Last update posted Jun 12, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies